Articles On Capitol Health (ASX:CAJ)
Title | Source | Codes | Date |
---|---|---|---|
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th... |
Stockhead | CAJ | 2 weeks ago |
Broker Upgrades: Whole is greater than the sum, as Jarden urges buying into IDX-CAJ merger
Jarden upgrades Integral Diagnostics after merger insights The broker highlights growth opportunities in imaging sector Australia’s deregulation boosts MRI access and revenue potential The imaging sector is by no means the sexiest part... |
Stockhead | CAJ | 4 weeks ago |
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
Healthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as Fed cuts rates How ASX biotechs performed in the month of September The S&P 500 Health Care Index, a key world benchmark for health... |
Stockhead | CAJ | 1 month ago |
Australian Broker Call *Extra* Edition – Sep 26, 2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha... |
FNArena | CAJ | 1 month ago |
US stocks surge to record highs after Fed rate cut
US stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new all-time highs, as traders cheered the Federal Reserve’s Wednesday decision to lower interest rates by half a percentage point. The 30-sto... |
ShareCafe | CAJ | 2 months ago |
The Overnight Report: Good Friday
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8210.00 + 73.00 0.90% S&P ASX 200 8191.90 +... |
FNArena | CAJ | 2 months ago |
US stocks surge to record highs after Fed rate cut
US stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new all-time highs, as traders cheered the Federal Reserve’s Wednesday decision to lower interest rates by half a percentage point. The 30-stock... |
ShareCafe | CAJ | 2 months ago |
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment The ASX Healthcare Index (AS... |
Stockhead | CAJ | 2 months ago |
Two up, one down: ASX healthcare stocks split after FY24 results
ASX healthcare stocks showed mixed results following the release of their most recent financials on Tuesday. Three companies in particular stand out, with two finishing in the green and one in the red. Integral Diagnostics Ltd (ASX: I... |
Motley Fool | CAJ | 2 months ago |
FNArena Corporate Results Monitor – 23-08-2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ACF)) - Acrow... |
FNArena | CAJ | 2 months ago |
ASX Reporting Season Highlights: Capitol Health, Genesis Energy, SkyCity Entertainment, and Medibank
As the 2024 fiscal year reporting season progresses, several key players across different sectors have revealed their financial performance, showcasing a mix of resilience and challenges. Diagnostic imaging provider Capitol Health, energy c... |
Kalkine Media | CAJ | 3 months ago |
The Overnight Report: Fed Sep Cut Coming
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7995.00 + 30.00 0.38% S&P ASX 200 8010.50 +... |
FNArena | CAJ | 3 months ago |
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July The S&P/ASX 200 Health Care index [XHJ]... |
Stockhead | CAJ | 3 months ago |
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month In a major blow for... |
Stockhead | CAJ | 3 months ago |
ASX 200 Drops Amid Wall Street Decline and Small Cap Retreat
Highlights: ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global economic updates. Big Tech stocks showed mixed results overnight, with Meta and Nvidia gaining, while Apple, Alphabet, and Amazon decline... |
Kalkine Media | CAJ | 4 months ago |
Weekly Ratings, Targets, Forecast Changes – 12-07-24
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha... |
FNArena | CAJ | 4 months ago |
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape
The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase... |
Stockhead | CAJ | 4 months ago |
Bell Potter names the best ASX healthcare stocks to buy in FY25
Looking for exposure to the healthcare sector in FY 2025? If you are, then check out the three ASX shares listed below. They have just been tipped as Bell Potter's top healthcare stocks to buy now: Aroa Biosurgery Ltd (ASX: ARX) Aroa Biosu... |
Motley Fool | CAJ | 4 months ago |
The Overnight Report: Friday Bounce
World Overnight SPI Overnight 7775.00 + 26.00 0.34% S&P ASX 200 7759.60 – 23.40 – 0.30% S&P500 5482.87 + 4.97 0.09% Nasdaq Comp 17858.68 + 53.53 0.30% DJIA 39164.06 + 36.26 0.09% S&P500 VIX 12.24 – 0.31 – 2.47% U... |
FNArena | CAJ | 4 months ago |
Why A2 Milk, Actinogen Medical, Karoon Energy, and Race Oncology shares are rising
The S&P/ASX 200 Index (ASX: XJO) is having a tough time on Wednesday after a stronger than expected inflation reading. In afternoon trade, the benchmark index is down 1% to 7,758.4 points. Four ASX shares that are not letting that hold... |
Motley Fool | CAJ | 4 months ago |
Guess which ASX healthcare stock is surging 15% on a 'major milestone'
Race Oncology Ltd (ASX: RAC) shares burst out of the gates on Wednesday morning. In early trade, the ASX healthcare stock was up as much as 15% to $1.96. The clinical stage biopharmaceutical company's shares have eased back a touch since th... |
Motley Fool | CAJ | 4 months ago |
3 ASX healthcare shares smashing new 52-week highs today
With the S&P/ASX 200 Health Care Index (ASX: XHJ) dipping slightly into the red on Wednesday, it's been a different story for three individual ASX healthcare shares. Pro Medicus Limited (ASX: PME), Race Oncology Ltd (ASX: RAC), and... |
Motley Fool | CAJ | 5 months ago |
How central banks are primed to drive a new ASX 200 gold stock rally
S&P/ASX 200 Index (ASX: XJO) gold stocks enjoyed a blistering rally from late February through to late May this year. That rally was driven by a surge in the gold price. On 28 February, the yellow metal was trading for US$2,030 per oun... |
Motley Fool | CAJ | 5 months ago |
Why Capitol Health, Infratil, Newmont, and Race Oncology shares are charging higher
The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday and storming higher. In afternoon trade, the benchmark index is up 0.95% to 7,773.6 points. Four ASX shares that are rising more than most today are listed below. Here's why t... |
Motley Fool | CAJ | 5 months ago |
Buy 'em now! Brokers name 3 ASX All Ords shares to add to your portfolio
The S&P/ASX All Ordinaries Index (ASX: XAO) is up 0.76% to 8,003.8 points in early trading on Tuesday. As reported in The Australian, 3 All Ords stocks have just gained buy ratings from top brokers. Let's check them out. Capst... |
Motley Fool | CAJ | 5 months ago |
Regional radiology chains agree to $857m merger
Integral Diagnostics and Capitol Health have agreed to join forces and create a 155-clinic diagnostic imaging company. |
The West | CAJ | 5 months ago |
Why Bapcor, Chalice Mining, Integral Diagnostics, and Winsome Resources shares are dropping
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,711.6 points. Four ASX shares that are falling more than most today are listed... |
Motley Fool | CAJ | 5 months ago |
This ASX All Ords stock is rocketing 20% after accepting a takeover offer
The market may be edging lower on Monday but that hasn't stopped one ASX All Ords stock from rocketing. In morning trade, the Capitol Health Ltd (ASX: CAJ) share price is up 20% to 29.5 cents. Why is this ASX All Ords stock rocketing? Inves... |
Motley Fool | CAJ | 5 months ago |
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month The S&P/ASX 200 Health Care [XHJ] closed flattish for the month o... |
Stockhead | CAJ | 5 months ago |
Buy this cheap small cap ASX share for a very big return
If you're looking for big returns, then it could be worth checking out the small side of the market. That's because in exchange for higher risk, investors have the potential for higher rewards. For example, the small cap ASX share in this a... |
Motley Fool | CAJ | 5 months ago |
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month The phrase ‘you are what you eat’ was coined almost a c... |
Stockhead | CAJ | 6 months ago |
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | CAJ | 6 months ago |
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | CAJ | 6 months ago |
Markets slide as new data raises renewed inflation fears
US markets kicked off the post Easter week by giving up ground on what was a winning month for March and a strong first quarter. New inflation data raised concerns that the Fed may struggle to hit its target of three rate cuts by the end... |
ShareCafe | CAJ | 7 months ago |
Rudi’s Comprehensive February 2024 Review
A compilation of stories relating to the February 2024 corporate reporting season in Australia, including FNArena’s final balance for the season. Content (in chronological order of publication): -Healthcare, REITs, Uranium & Banks-Rudi... |
FNArena | CAJ | 7 months ago |
Capitol Health’s Higher Margin Outlook
Capitol Health’s first half results exceeded brokers’ expectations with higher margins thanks largely to good cost control. -Brokers raise targets following Capitol Health’s first half results-The earnings margin increased by 200bps due to... |
FNArena | CAJ | 8 months ago |
Australian Broker Call *Extra* Edition – Mar 12, 2024
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now... |
FNArena | CAJ | 8 months ago |
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr... |
Stockhead | CAJ | 8 months ago |
Nasdaq pulls back after steep declines from big tech names
US stocks fell for a second session Tuesday, as steep declines in major tech names such as Apple dragged the broader market further from the record highs recently reached. The Nasdaq Composite pulled back by 1.65 per cent to 15,939.59 as... |
ShareCafe | CAJ | 8 months ago |
FNArena Corporate Results Monitor – 01-03-2024
Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((ALX)) - Atlas Arteria ((AFG)) - Australian Finance Group ((CAJ)) - Capitol Health ((CLU)) - Cluey ((DOC)) - Docto... |
FNArena | CAJ | 8 months ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | CAJ | 8 months ago |
ESG Focus: The Little Big Things – 30-11-2023
FNArena's dedicated ESG Focus news section zooms in on matters Environmental, Social & Governance (ESG) that are increasingly guiding investors preferences and decisions globally. For more news updates, past and future: https://www.fnar... |
FNArena | CAJ | 11 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | CAJ | 1 year ago |
CAJ ASX | Capitol Health Ltd | Market Insights, News & Analysis | Livewire
|
Livewire | CAJ | 1 year ago |
US stocks slide following comments from Fed Chair Jay Powell
Stocks slid on Thursday as Wall Street parsed commentary from Federal Reserve Chair Jerome Powell while monitoring a key milestone for a closely followed bond yield. Powell noted that inflation was still too high and would likely require lo... |
ShareCafe | CAJ | 1 year ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | CAJ | 1 year ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | CAJ | 1 year ago |
Stocks dip as Fed holds rates steady, hints at future hike
Stocks retreated on Wednesday after the Federal Reserve said it would leave interest rates unchanged but indicated another hike on the horizon. The three major indexes closed at session lows. The S&P 500 dropped 0.94 per cent to 4,402... |
ShareCafe | CAJ | 1 year ago |
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks On... |
Stockhead | CAJ | 1 year ago |
Rudi’s View: Outlook Negative, With Plenty Of Silver Linings
In this week's Weekly Insights:-Outlook Negative, With Plenty Of Silver Linings-Conviction Calls & Best IdeasBy Rudi Filapek-Vandyck, EditorOne of the stand-out features of the August results season has been the resilience of household ... |
FNArena | CAJ | 1 year ago |